Cargando…

Pharmaceutical companies information and antibiotic prescription patterns: A follow-up study in Spanish primary care

OBJECTIVES: To assess the impact of sources of drug information on antibiotic prescribing patterns (quantity and quality) among primary care physicians. METHODS: We conducted a cohort study on primary care physicians who were actively engaged in medical practice in 2010 in a region in north-west Spa...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Álvarez, Iria, Zapata-Cachafeiro, Maruxa, Vázquez-Lago, Juan, López-Vázquez, Paula, Piñeiro-Lamas, María, García Rodríguez, Raquel, Figueiras, Adolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706057/
https://www.ncbi.nlm.nih.gov/pubmed/31437201
http://dx.doi.org/10.1371/journal.pone.0221326
_version_ 1783445649132355584
author Fernández-Álvarez, Iria
Zapata-Cachafeiro, Maruxa
Vázquez-Lago, Juan
López-Vázquez, Paula
Piñeiro-Lamas, María
García Rodríguez, Raquel
Figueiras, Adolfo
author_facet Fernández-Álvarez, Iria
Zapata-Cachafeiro, Maruxa
Vázquez-Lago, Juan
López-Vázquez, Paula
Piñeiro-Lamas, María
García Rodríguez, Raquel
Figueiras, Adolfo
author_sort Fernández-Álvarez, Iria
collection PubMed
description OBJECTIVES: To assess the impact of sources of drug information on antibiotic prescribing patterns (quantity and quality) among primary care physicians. METHODS: We conducted a cohort study on primary care physicians who were actively engaged in medical practice in 2010 in a region in north-west Spain (Galicia), fulfilling inclusion criteria (n = 2100). As the independent variable, we took the perceived utility of 6 sources of information on antibiotics, as measured by the validated KAAR-11 questionnaire. As dependent variables, we used: (1) a quality indicator (appropriate quality, defined as any case where 6 of the 12 indicators proposed by the European Surveillance of Antimicrobial Consumption Network [ESAC-Net] were better than the mean values for Spain); and, (2) a quantity indicator (high prescribing), defined as any case where defined daily doses (DDD) per 1 000 inhabitants per day of antibacterials for systemic use were higher than the mean values for Spain. The adjusted odds ratio for a change in the interquartile range (IqOR) for each sources of information on antibiotics was calculated using Generalized Linear Mixed Models. RESULTS: The questionnaire response rate was 68%. Greater perceived utility of pharmaceutical sales representatives increases the risk of having high prescribing (1/IqOR = 2.50 [95%CI: 1.63–3.66]) and reduces the probability of having appropriate quality (1/IqOR = 2.28 [95%CI: 1.77–3.01]). Greater perceived utility of clinical guidelines increases the probability of having appropriate quality (1/IqOR = 1.25 [95%CI: 1.02–1.54]) and reduces the probability of high prescribing (1/IqOR = 1.25 [95%CI: 1.02–1.54]). CONCLUSIONS: Sources of information on antibiotics are an important determinant of the quantity and quality of antibiotic prescribing in primary care. Commercial sources of information influence prescribing negatively, and clinical guidelines are associated with better indicators.
format Online
Article
Text
id pubmed-6706057
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-67060572019-09-04 Pharmaceutical companies information and antibiotic prescription patterns: A follow-up study in Spanish primary care Fernández-Álvarez, Iria Zapata-Cachafeiro, Maruxa Vázquez-Lago, Juan López-Vázquez, Paula Piñeiro-Lamas, María García Rodríguez, Raquel Figueiras, Adolfo PLoS One Research Article OBJECTIVES: To assess the impact of sources of drug information on antibiotic prescribing patterns (quantity and quality) among primary care physicians. METHODS: We conducted a cohort study on primary care physicians who were actively engaged in medical practice in 2010 in a region in north-west Spain (Galicia), fulfilling inclusion criteria (n = 2100). As the independent variable, we took the perceived utility of 6 sources of information on antibiotics, as measured by the validated KAAR-11 questionnaire. As dependent variables, we used: (1) a quality indicator (appropriate quality, defined as any case where 6 of the 12 indicators proposed by the European Surveillance of Antimicrobial Consumption Network [ESAC-Net] were better than the mean values for Spain); and, (2) a quantity indicator (high prescribing), defined as any case where defined daily doses (DDD) per 1 000 inhabitants per day of antibacterials for systemic use were higher than the mean values for Spain. The adjusted odds ratio for a change in the interquartile range (IqOR) for each sources of information on antibiotics was calculated using Generalized Linear Mixed Models. RESULTS: The questionnaire response rate was 68%. Greater perceived utility of pharmaceutical sales representatives increases the risk of having high prescribing (1/IqOR = 2.50 [95%CI: 1.63–3.66]) and reduces the probability of having appropriate quality (1/IqOR = 2.28 [95%CI: 1.77–3.01]). Greater perceived utility of clinical guidelines increases the probability of having appropriate quality (1/IqOR = 1.25 [95%CI: 1.02–1.54]) and reduces the probability of high prescribing (1/IqOR = 1.25 [95%CI: 1.02–1.54]). CONCLUSIONS: Sources of information on antibiotics are an important determinant of the quantity and quality of antibiotic prescribing in primary care. Commercial sources of information influence prescribing negatively, and clinical guidelines are associated with better indicators. Public Library of Science 2019-08-22 /pmc/articles/PMC6706057/ /pubmed/31437201 http://dx.doi.org/10.1371/journal.pone.0221326 Text en © 2019 Fernández-Álvarez et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Fernández-Álvarez, Iria
Zapata-Cachafeiro, Maruxa
Vázquez-Lago, Juan
López-Vázquez, Paula
Piñeiro-Lamas, María
García Rodríguez, Raquel
Figueiras, Adolfo
Pharmaceutical companies information and antibiotic prescription patterns: A follow-up study in Spanish primary care
title Pharmaceutical companies information and antibiotic prescription patterns: A follow-up study in Spanish primary care
title_full Pharmaceutical companies information and antibiotic prescription patterns: A follow-up study in Spanish primary care
title_fullStr Pharmaceutical companies information and antibiotic prescription patterns: A follow-up study in Spanish primary care
title_full_unstemmed Pharmaceutical companies information and antibiotic prescription patterns: A follow-up study in Spanish primary care
title_short Pharmaceutical companies information and antibiotic prescription patterns: A follow-up study in Spanish primary care
title_sort pharmaceutical companies information and antibiotic prescription patterns: a follow-up study in spanish primary care
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706057/
https://www.ncbi.nlm.nih.gov/pubmed/31437201
http://dx.doi.org/10.1371/journal.pone.0221326
work_keys_str_mv AT fernandezalvareziria pharmaceuticalcompaniesinformationandantibioticprescriptionpatternsafollowupstudyinspanishprimarycare
AT zapatacachafeiromaruxa pharmaceuticalcompaniesinformationandantibioticprescriptionpatternsafollowupstudyinspanishprimarycare
AT vazquezlagojuan pharmaceuticalcompaniesinformationandantibioticprescriptionpatternsafollowupstudyinspanishprimarycare
AT lopezvazquezpaula pharmaceuticalcompaniesinformationandantibioticprescriptionpatternsafollowupstudyinspanishprimarycare
AT pineirolamasmaria pharmaceuticalcompaniesinformationandantibioticprescriptionpatternsafollowupstudyinspanishprimarycare
AT garciarodriguezraquel pharmaceuticalcompaniesinformationandantibioticprescriptionpatternsafollowupstudyinspanishprimarycare
AT figueirasadolfo pharmaceuticalcompaniesinformationandantibioticprescriptionpatternsafollowupstudyinspanishprimarycare
AT pharmaceuticalcompaniesinformationandantibioticprescriptionpatternsafollowupstudyinspanishprimarycare